Skip to main content

Examples of how pharmaceutical and medical companies are addressing unmet health needs in low- and middle- income economies, creating shared value by providing products and services that tackle global health problems.

Top Takeaways

  1. Low- and middle-income countries have vast unmet health needs, and many are combating infectious diseases and non-communicable diseases at once and on a massive scale.
  2. These countries present an enormous opportunity for pharmaceutical companies—emerging markets are expected to account for 75% of industry growth in the next 10 years.
  3. To achieve sustainable and scalable solutions to addressing global health issues, companies must move beyond philanthropy, and create new products and systems.

A common assumption, that companies have little commercial interest in meeting the health needs of the world’s underserved in low- and middle-income countries, is being disproven by changing populations, disease burdens, and economic conditions.

Watch the Webinar


View the webinar presentation